Capstone Investment Advisors’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.43M | Sell |
6,000
-800
| -12% | -$166K | ﹤0.01% | 834 |
|
|
2026
Q1 | $1.44M | Buy |
6,800
+3,700
| +119% | +$797K | ﹤0.01% | 734 |
|
|
2025
Q4 | $637K | Sell |
3,100
-2,000
| -39% | -$376K | ﹤0.01% | 1051 |
|
|
2025
Q3 | $800K | Buy |
5,100
+1,300
| +34% | +$201K | ﹤0.01% | 1119 |
|
|
2025
Q2 | $638K | Sell |
3,800
-3,100
| -45% | -$460K | ﹤0.01% | 1033 |
|
|
2025
Q1 | $951K | Sell |
6,900
-7,500
| -52% | -$956K | ﹤0.01% | 898 |
|
|
2024
Q4 | $1.7M | Buy |
14,400
+5,300
| +58% | +$619K | ﹤0.01% | 893 |
|
|
2024
Q3 | $1.01M | Buy |
9,100
+300
| +3% | +$31.4K | ﹤0.01% | 961 |
|
|
2024
Q2 | $865K | Buy |
8,800
+800
| +10% | +$81.5K | ﹤0.01% | 1051 |
|
|
2024
Q1 | $895K | Sell |
8,000
-1,600
| -17% | -$173K | ﹤0.01% | 1214 |
|
|
2023
Q4 | $968K | Buy |
9,600
+1,100
| +13% | +$109K | ﹤0.01% | 1062 |
|
|
2023
Q3 | $738K | Buy |
8,500
+3,100
| +57% | +$280K | ﹤0.01% | 1116 |
|
|
2023
Q2 | $511K | Buy |
5,400
+300
| +6% | +$25.3K | ﹤0.01% | 1152 |
|
|
2023
Q1 | $385K | Buy |
+5,100
| New | +$385K | ﹤0.01% | 1089 |
|
|
2022
Q4 | – | Sell |
-4,100
| Closed | -$273K | – | 1530 |
|
|
2022
Q3 | $273K | Buy |
4,100
+400
| +11% | +$25.4K | ﹤0.01% | 1405 |
|
|
2022
Q2 | $193K | Sell |
3,700
-27,100
| -88% | -$1.54M | ﹤0.01% | 1424 |
|
|
2022
Q1 | $1.75M | Sell |
30,800
-5,200
| -14% | -$278K | ﹤0.01% | 1124 |
|
|
2021
Q4 | $1.85M | Buy |
36,000
+5,400
| +18% | +$265K | ﹤0.01% | 1139 |
|
|
2021
Q3 | $1.51M | Sell |
30,600
-5,900
| -16% | -$320K | ﹤0.01% | 1288 |
|
|
2021
Q2 | $2.08M | Buy |
36,500
+8,900
| +32% | +$520K | ﹤0.01% | 1010 |
|
|
2021
Q1 | $1.68M | Buy |
27,600
+16,400
| +146% | +$905K | ﹤0.01% | 984 |
|
|
2020
Q4 | $600K | Sell |
11,200
-7,500
| -40% | -$389K | ﹤0.01% | 1214 |
|
|
2020
Q3 | $878K | Buy |
18,700
+6,300
| +51% | +$323K | ﹤0.01% | 1045 |
|
|
2020
Q2 | $647K | Buy |
12,400
+5,200
| +72% | +$268K | ﹤0.01% | 1025 |
|
|
2020
Q1 | $345K | Sell |
7,200
-33,500
| -82% | -$1.74M | 0.01% | 950 |
|
|
2019
Q4 | $2.06M | Buy |
40,700
+17,900
| +79% | +$925K | 0.01% | 822 |
|
|
2019
Q3 | $1.08M | Sell |
22,800
-16,000
| -41% | -$730K | 0.01% | 918 |
|
|
2019
Q2 | $1.83M | Buy |
38,800
+25,900
| +201% | +$1.19M | 0.01% | 768 |
|
|
2019
Q1 | $621K | Buy |
12,900
+7,500
| +139% | +$376K | 0.01% | 949 |
|
|
2018
Q4 | $241K | Buy |
5,400
+2,600
| +93% | +$136K | ﹤0.01% | 989 |
|
|
2018
Q3 | $151K | Buy |
+2,800
| New | +$143K | ﹤0.01% | 1066 |
|
Other funds holding CAH
Capstone Investment Advisors's CAH Position: Q2 2026 in Review
Capstone Investment Advisors reduced its Cardinal Health (CAH) stake by 25% in Q2 2026, selling an estimated $150K and leaving 2,203 shares worth $523K. The position accounts for ﹤0.01% of the portfolio, ranked #1223.
Capstone Investment Advisors first reported a position in CAH in Q3 2015 and has held it in 20 quarters since. The position peaked at $3.5M in Q3 2021. 1,501 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Capstone Investment Advisors held 2,203 shares of Cardinal Health worth $523K as of Q2 2026.
- Capstone Investment Advisors sold 720 Cardinal Health shares in Q2 2026, an estimated $150K.
- Cardinal Health made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1223 holding.
- Capstone Investment Advisors first reported a position in Cardinal Health in Q3 2015 and has held it in 20 quarters since.
- Capstone Investment Advisors's Cardinal Health position peaked at $3.5M in Q3 2021.
- 1,501 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.